Drug Description in Trials / DrugBank / KEGG DRUG
Search results
| No. | Drug (Description in trials) | DrugBank | KEGG DRUG | KEGG GENES | KEGG PATHWAY | Disease ID |
|---|---|---|---|---|---|---|
| 1 | Betamethasone | [1] Betamethasone Betamethasone | [7] D00244
D00244
(Name: Betamethasone),D00972 (Name: Betamethasone sodium phosphate), D01357 (Name: Betamethasone valerate), D01402 (Name: Betamethasone acetate), D01637 (Name: Betamethasone dipropionate), D02032 (Name: Betamethasone butyrate propionate), D02286 (Name: Betamethasone benzoate) | [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [7] 2 2, 28, 46, 83, 90, 96, 235 |
| 2 | BETAMETHASONE ACIBUTATE | [1] Betamethasone Betamethasone | [7] D00244
D00244
(Name: Betamethasone),D00972 (Name: Betamethasone sodium phosphate), D01357 (Name: Betamethasone valerate), D01402 (Name: Betamethasone acetate), D01637 (Name: Betamethasone dipropionate), D02032 (Name: Betamethasone butyrate propionate), D02286 (Name: Betamethasone benzoate) | [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 46 46 |
| 3 | Betamethasone sodium phosphate/betamethasone acetate (Celestone® Soluspan®), 30 mg IM once a day for four days | [3] Acetate Acetate,Betamethasone, Phosphate ion | [7] D00244
D00244
(Name: Betamethasone),D00972 (Name: Betamethasone sodium phosphate), D01357 (Name: Betamethasone valerate), D01402 (Name: Betamethasone acetate), D01637 (Name: Betamethasone dipropionate), D02032 (Name: Betamethasone butyrate propionate), D02286 (Name: Betamethasone benzoate) | [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 2 2 |
| 4 | Intra-articular Compound Betamethasone | [1] Betamethasone Betamethasone | [7] D00244
D00244
(Name: Betamethasone),D00972 (Name: Betamethasone sodium phosphate), D01357 (Name: Betamethasone valerate), D01402 (Name: Betamethasone acetate), D01637 (Name: Betamethasone dipropionate), D02032 (Name: Betamethasone butyrate propionate), D02286 (Name: Betamethasone benzoate) | [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 46 46 |
| 5 | Intraarticular betamethasone | [1] Betamethasone Betamethasone | [7] D00244
D00244
(Name: Betamethasone),D00972 (Name: Betamethasone sodium phosphate), D01357 (Name: Betamethasone valerate), D01402 (Name: Betamethasone acetate), D01637 (Name: Betamethasone dipropionate), D02032 (Name: Betamethasone butyrate propionate), D02286 (Name: Betamethasone benzoate) | [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 46 46 |
| 6 | Phosphate and betamethasone acetate, 2 mL. | [3] Acetate Acetate,Betamethasone, Phosphate ion | [7] D00244
D00244
(Name: Betamethasone),D00972 (Name: Betamethasone sodium phosphate), D01357 (Name: Betamethasone valerate), D01402 (Name: Betamethasone acetate), D01637 (Name: Betamethasone dipropionate), D02032 (Name: Betamethasone butyrate propionate), D02286 (Name: Betamethasone benzoate) | [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 235 235 |